- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02587156
Fate of Nutrient-Derived Amino Acids, FONDAA (FONDAA)
Fate of Nutrient-Derived Amino Acids: Influence of Habituated Levels of Daily Dietary Protein Intake on Protein Utilization
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Copenhagen, Denmark, 2400
- Institute of Sports Medicine Copenhagen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Exclusion Criteria:
- Hyperlipidemia
- Hypertension
Inclusion Criteria:
- Males age 65-70
- Independently dwelling
- Without any major health issues (blood pressure, cholesterol and lipid profile will be measured and evaluated by a physician)
- Non-diabetic
- No organ disease
- No back pain
- Not regularly take any prescription drugs or dietary supplements, which can influence muscle protein synthesis
- Alcohol intake below 21 units pr. week
- No known arthrosclerosis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Meal serving at high dietary protein
Test the handling of meal-served protein when habituated to high dietary protein at an amount above 1.5 g protein/kg/day
|
Participants are habituated to a high level of dietary protein intake for 21 days.
To investigate impact of habituated protein level
|
Active Comparator: Meal serving at low dietary protein
Test the handling of meal-served protein when habituated to high dietary protein at an amount below 0.8 g protein/kg/day
|
To investigate impact of habituated protein level
Participants are habituated to a low level of dietary protein intake for 21 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Abundance of milk protein-bound amino acid labels in blood protein.
Time Frame: Baseline to 240 min postprandial
|
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet: After intake of milk proteins at time 0 (zero) the quantity of intrinsic labels D5-phe from whey and 15N-phe from casein will be measured in liver-synthesized blood protein at 240 min. |
Baseline to 240 min postprandial
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Abundance of milk protein-bound amino acid labels in myofibrillar protein.
Time Frame: Baseline to 240 min postprandial
|
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet: After intake of milk proteins at time 0 (zero) the quantity of intrinsic labels D5-phe from whey and 15N-phe from casein will be measured in myofibrillar protein at 240 min. |
Baseline to 240 min postprandial
|
Leg phenylalanine rate of disappearance and appearance, net balance.
Time Frame: Baseline to 240 min postprandial
|
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet: From arterial and femoral venous blood samples obtained at baseline, 30, 60, 90, 120, 150, 180, 240 min phenylalanine tracer enrichments and concentrations as well as plasma flow will be measured. |
Baseline to 240 min postprandial
|
First pass splanchnic extraction of dietary protein-derived labeled phenylalanine.
Time Frame: Baseline to 240 min postprandial
|
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet: From hepatic venous blood samples obtained at baseline, 30, 60, 90, 120, 150, 180, 240 min phenylalanine tracer enrichments and concentrations as well as plasma flow will be measured. Knowing the amount of ingested protein and labeled phenylalanine we can calculate the first pass splanchnic amino acid extraction. |
Baseline to 240 min postprandial
|
Whole body phenylalanine rate of disappearance and appearance, net balance.
Time Frame: Baseline to 240 min postprandial
|
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet: From blood samples obtained at baseline, 30, 60, 90, 120, 150, 180, 240 min phenylalanine tracer enrichments will be measured. |
Baseline to 240 min postprandial
|
The myofibrillar protein fractional synthesis rate
Time Frame: Baseline to 240 min postprandial
|
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet: From muscle biopsies obtained at baseline, 60 and 240 min the abundance of phenylalanine tracer bound in the myofibrillar proteins will be measured and the fractional synthesis rate will be measured within the first from baseline to 60 min and 240 min as well as from 60-240 min postprandial. |
Baseline to 240 min postprandial
|
Response of expression of proteins involved in muscle protein turnover
Time Frame: Baseline, 60 min and 240 min postprandial
|
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet: From baseline to 60 and 240 min after intake of the standardized meal after 21 days of habituation to either a high or a low dietary protein intake expression of signalling proteins related to protein turnover in the muscle will be measured by use of western blotting. |
Baseline, 60 min and 240 min postprandial
|
Urea production.
Time Frame: Baseline to 240 min postprandial
|
Related to the trials conducted after 21 days of habituation to either high or low protein in the diet: From blood samples obtained at baseline, 30, 60, 90, 120, 150, 180, 240 min urea tracer enrichments and concentrations will be measured. With this, and flow measurements, we can determine the rate of urea production. |
Baseline to 240 min postprandial
|
Nitrogen and creatinine excreted in urine
Time Frame: 21 days post intervention, 240 min postprandial and 24 hours post the day 21 trial day
|
Related to the adaptation to the 21 day habituation period to either high or low protein in the diet as well as the response to the standardized trial meal: Nitrogen and creatinine content is measured in urine is collected for the last 24 h of the 21 day habituation period, as well as during the 240 min trial day and the remaining 20 hours of the trial day. |
21 days post intervention, 240 min postprandial and 24 hours post the day 21 trial day
|
Fecal microbiota composition
Time Frame: Change from pre-intervention to 21 days and 22 days (21 intervention days habituation and the standardized trial meal on day 21)
|
Related to the adaptation to the 21 day habituation period to either high or low protein in the diet as well as the response to the standardized trial meal: The microbiota compositions, will be measured in fecal samples collected before the 21 day habituation period, after the 21 day habituation periode, as well as after the 240 min trial day |
Change from pre-intervention to 21 days and 22 days (21 intervention days habituation and the standardized trial meal on day 21)
|
Adaptation of expression of proteins involved in muscle protein turnover
Time Frame: After 21 days of habituation to either a high or a low dietary protein intake.
|
Related to the adaptation to the 21 day habituation period to either high or low protein in the diet: Biopsies taken following the two 21 day habituation period will, by use of western blotting, be analysed for expression of signalling proteins involved in muscle protein turnover. |
After 21 days of habituation to either a high or a low dietary protein intake.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Grith Højfeldt, M.Sc., Bispebjerg Hospital
- Principal Investigator: Lars Holm, Ph.D., Bispebjerg Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- BBH122
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dietary Protein
-
Purdue UniversityCompletedLow Protein Dietary Intake | High Protein Dietary IntakeUnited States
-
University of Illinois at Urbana-ChampaignNational Cattlemen's Beef AssociationRecruitingDietary Habits | Muscle Protein Synthesis | Meal FrequencyUnited States
-
University of TorontoNatural Sciences and Engineering Research Council, CanadaCompletedResistance Exercise | Amino Acids | Dietary Protein | SexCanada
-
University of TorontoRecruitingResistance Exercise | Dietary Protein | Female Protein Metabolism | Anabolic Sensitivity | Young Adult FemalesCanada
-
Washington University School of MedicineActive, not recruitingDietary ProteinUnited States
-
University of TorontoRecruitingPhysical Inactivity | Resistance Exercise | Amino Acids | Dietary ProteinCanada
-
University of ReadingUnknownDietary Habits | Dietary ModificationUnited Kingdom
-
University of ReadingCompletedDietary Habits | Dietary ModificationUnited Kingdom
-
The University of Tennessee, KnoxvilleCompletedDietary Assessment | 24-hour Dietary Recall | Dietary Restraint | Social DesirabilityUnited States
-
Brown UniversityNational Cancer Institute (NCI); University of ConnecticutCompletedDietary Habits | Dietary Modification
Clinical Trials on Meal serving at high dietary protein
-
Khyber Medical University PeshawarRecruitingObesity, OverweightPakistan
-
Ryerson UniversityCompletedObesity | OverweightCanada
-
University of Missouri-ColumbiaRecruiting
-
Medical University of BialystokMinistry of Science and Higher Education, PolandCompletedDiabetes Mellitus, Type 2 | Metabolic Syndrome | Diet Modification | Overweight and Obesity | Genetic PredispositionPoland
-
Northumbria UniversityCompleted
-
University of Eastern FinlandRecruitingOverweight and Obesity | Postprandial Hyperglycemia | Type2diabetesFinland
-
Imperial College LondonCompletedOverweight | Metabolic Syndrome | Obese | Non Alcoholic Fatty Liver DiseaseUnited Kingdom
-
University of StirlingCompleted
-
Örebro University, SwedenRecruitingIleostomy - StomaSweden
-
University of LausanneCompleted